pharmaphorum

MARCH 29, 2022

With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race to secure access to the developed vaccines. In this article, Ben Hargreaves examines how wealth determined the winners and what is now underway to help lower-income countries gain access to the available vaccines.

Vaccines 95

Vaccines Generic Medicine 95

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. You can read part one of this article here. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

European Pharmaceutical Review

DECEMBER 19, 2022

A generic medicine, Diethyl fumarate Accord (dimethyl fumarate), received a positive opinion for the treatment of multiple sclerosis (MS), a chronic disease affecting the central nervous system. The CHMP completed reviews under Article 29(4), following disagreements among EU Member States regarding two medicines authorisations.

Generic Medicine 104

Generic Medicine Vaccines Chemotherapy 104

European Pharmaceutical Review

NOVEMBER 14, 2022

Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. COVID-19 update. 5 in children five to 11 years. CHMP’s safety update.

Vaccines 98

Vaccines Generic Medicine 98

pharmaphorum

MAY 26, 2022

The race to produce a vaccine which could protect the world against COVID-19 brought the topic of diversity in clinical trials, or lack of it, into sharp focus. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy. The pandemic brought imbalances into sharp focus. About the authors.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143

European Pharmaceutical Review

FEBRUARY 3, 2025

CHMP’s positive opinions for vaccines In addition, the human medicines committee recommended the vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine (21-valent)), as a preventative treatment for invasive disease and pneumonia caused by streptococcus pneumoniae bacteria in adults.

Generic Medicine 52

Generic Medicine Vaccines Chemotherapy Immunization 52